Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.
Parkinson's disease (PD) without (non-demented, PDND) and with dementia (PDD), and dementia with Lewy bodies (DLB) are subsumed under the umbrella term Lewy body disorders (LBD). The main component of the underlying pathologic substrate, i.e. Lewy bodies and Lewy neurites, is misfolded alpha-sy...
Main Authors: | Walter Maetzler, Youyong Tian, Stephanie Maria Baur, Tina Gauger, Bartholomäus Odoj, Benjamin Schmid, Claudia Schulte, Christian Deuschle, Susanna Heck, Anja Apel, Arthur Melms, Thomas Gasser, Daniela Berg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23133543/pdf/?tool=EBI |
Similar Items
-
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.
by: Walter Maetzler, et al.
Published: (2016-01-01) -
Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
by: Elizabeta B. Mukaetova-Ladinska, et al.
Published: (2010-01-01) -
No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases
by: Walter Maetzler, et al.
Published: (2009-08-01) -
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
by: Inger van Steenoven, et al.
Published: (2019-09-01) -
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
by: Inger van Steenoven, et al.
Published: (2019-10-01)